BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of a single intra-articular injection of 2
doses of BOTOX® (onabotulinumtoxinA) compared with placebo as treatment for knee
osteoarthritis symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA